Starpharma Holdings Limited (ASX:SPL)

Australia · Delayed Price · Currency is AUD

0.405

+0.010 (2.53%)

At close: Mar 6, 2026

Starpharma Holdings Employees

Starpharma Holdings had 40 employees as of June 30, 2025. The number of employees did not change compared to the previous year.

Employees

40

Change (1Y)

n/a

Growth (1Y)

n/a

Revenue / Employee

364.45K AUD

Profits / Employee

-80.78K AUD

Market Cap

170.07M

Employees Chart

Employees History

Date	Employees	Change	Growth
Jun 30, 2025	40	0	-
Jun 30, 2024	40	-5	-11.11%
Jun 30, 2023	45	-5	-10.00%
Jun 30, 2022	50	0	-
Jun 30, 2021	50	5	11.11%
Jun 30, 2020	Pro	Pro	Pro

Starpharma Holdings News

2 years ago - Starpharma: Patience Needed, But A Lot To Like - Seeking Alpha
3 years ago - Starpharma presents compelling data in Prostate Cancer at ESMO - PRNewsWire
3 years ago - Starpharma signs new DEP® agreement with MSD - PRNewsWire
4 years ago - Starpharma releases positive DEP® phase 2 interim results in prostate cancer - PRNewsWire
4 years ago - US Patent and Trademark Office grants new patent for DEP® cabazitaxel, one of Starpharma's phase 2 clinical-stage cancer treatments - PRNewsWire
4 years ago - Stopping Infection: A Missing Link In The Delta Puzzle? Unloved Investment Opportunity In Starpharma - Seeking Alpha
5 years ago - Early-Stage Covid Treatment Prospects: Merck/Ridgeback Bio And Starpharma Lead The Pack - Seeking Alpha
5 years ago - Starpharma Up With News, Down With None; Timing Entry Makes Sense - Seeking Alpha